Results 141 to 150 of about 4,908,769 (289)

OGFRL1 Deficiency Causes Chronic Recurrent Multifocal Osteomyelitis Via Pathologic Osteoclastogenesis, With Therapeutic Response to Tumor Necrosis Factor Inhibitor

open access: yesArthritis &Rheumatology, EarlyView.
Objective To verify the pathogenesis of the opioid growth factor receptor like‐1 (OGFRL1) loss‐of‐function variant (c.30del, p. F10Ffs*110) identified in a patient with chronic recurrent multifocal osteomyelitis (CRMO) and to investigate the underlying mechanism.
Wen Xiong   +9 more
wiley   +1 more source

Association between the use of Sci-Hub and consultation of scientific journals by medical students from six Latin American countries: A secondary analysis. [PDF]

open access: yesHeliyon, 2023
Valladares-Garrido MJ   +7 more
europepmc   +1 more source

Fiscal year 1981 scientific and technical reports, articles, papers, and presentations [PDF]

open access: yes
This bibliography lists approximately 503 formal NASA technical reports, papers published in technical journals, and presentations by MSFC personnel in FY-1981. It also includes papers of MSFC contractors.
Thacker, S. S.
core   +1 more source

Increased submissions to ophthalmology scientific journals during the COVID-19 pandemic. [PDF]

open access: yesCont Lens Anterior Eye, 2022
Erdinest N   +3 more
europepmc   +1 more source

Investigating the Role of Type I Interferon Signaling on Muscle Disease Using Mouse Models

open access: yesArthritis &Rheumatology, EarlyView.
Objective Dysregulated type I interferon (IFN) signaling contributes to autoimmune myositis pathogenesis. We investigated the therapeutic effects of JAK inhibitors in two mouse models. We also examined how type I IFNs affect muscle vasculature. Methods Myositis was induced in major histocompatibility complex class I double transgenic ([TRE‐H‐2Kb (H ...
Rita Spathis   +11 more
wiley   +1 more source

Povećanje vidljivosti hrvatskih znanstvenih časopisa [PDF]

open access: yesKemija u Industriji, 2007
Dravec Braun, J.
doaj  

Inosine‐Triphosphate‐Pyrophosphatase Activity as a Potential Predictor of Methotrexate Remission in Juvenile Idiopathic Arthritis

open access: yesArthritis &Rheumatology, EarlyView.
Objective Methotrexate (MTX) is the first‐line therapy for juvenile idiopathic arthritis (JIA), but up to 40% of patients do not respond to it. Low inosine triphosphate pyrophosphatase (ITPA) activity has been associated with reduced clinical remission. We investigated the role and underlying mechanisms of ITPA in vitro. Methods ITPA enzymatic activity
Sofia Sindici Forgiarini   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy